Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma
Ana M. Franceschi(University at Buffalo, State University of New York), Yueh Z. Lee(University of North Carolina at Chapel Hill), Samuel Glaubiger(University of North Carolina at Chapel Hill), Stergios J. Moschos(University of North Carolina at Chapel Hill), Carrie B. Lee(University of North Carolina at Chapel Hill), Frances A. Collichio(Institute for Tourism), Maurício Castillo(University of North Carolina at Chapel Hill), Carey K. Anders(Duke University)
Cited by 31
Related Papers
Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEYNOTE-002): a randomised, controlled, phase 2 trial
|The Lancet Oncology|2015|1.6k
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer
|New England Journal of Medicine|2019|1.3k
Brain metastases
|Nature Reviews Disease Primers|2019|1.1k
Young Age at Diagnosis Correlates With Worse Prognosis and Defines a Subset of Breast Cancers With Shared Patterns of Gene Expression
|Journal of Clinical Oncology|2008|917
Breast Cancer Before Age 40 Years
|Seminars in Oncology|2009|795